Introduction
Publisher
Springer Singapore
Reference281 articles.
1. Adachi, Y., Sakamoto, K., Umemoto, T., Fukuda, Y., Tani, A., & Asami, T. (2017). Investigation on cellular uptake and pharmacodynamics of DOCK2-inhibitory peptides conjugated with cell-penetrating peptides. Bioorganic & Medicinal Chemistry, 25, 2148–2155. 2. Akishiba, M., Takeuchi, T., Kawaguchi, Y., Sakamoto, K., Yu, H. H., Nakase, I., et al. (2017). Cytosolic antibody delivery by lipid-sensitive endosomolytic peptide. Nature Chemistry, 9, 751–761. 3. Alaybeyoglu, B., Uluocak, B. G., Akbulut, B. S., & Ozkirimli, E. (2017). The effect of a beta-lactamase inhibitor peptide on bacterial membrane structure and integrity: A comparative study. Journal of Peptide Science, 23, 374–383. 4. Alberici, L., Roth, L., Sugahara, K. N., Agemy, L., Kotamraju, V. R., Teesalu, T., et al. (2013). De novo design of a tumor-penetrating peptide. Cancer Research, 73, 804–812. 5. Alexander-Bryant, A. A., Dumitriu, A., Attaway, C. C., Yu, H., & Jakymiw, A. (2015). Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. Journal of Controlled Release: Official Journal of the Controlled Release Society, 218, 72–81.
|
|